AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Mooij, P Heeney, JL
Citation: P. Mooij et Jl. Heeney, Rational development of prophylactic HIV vaccines based on structural and regulatory proteins, VACCINE, 20(3-4), 2001, pp. 304-321

Authors: Balla-Jhagjhoorsingh, SS Mooij, P ten Haaft, PJF Bogers, WMJM Teeuwsen, VJP Koopman, G Heeney, JL
Citation: Ss. Balla-jhagjhoorsingh et al., Protection from secondary human immunodeficiency virus type 1 infection inchimpanzees suggests the importance of antigenic boosting and a possible role for cytotoxic T cells, J INFEC DIS, 184(2), 2001, pp. 136-143

Authors: Balla-Jhagjhoorsingh, SS Mooij, P ten Haaft, PJF Bogers, WMJM Teeuwsen, VJP Koopman, G Heeney, JL
Citation: Ss. Balla-jhagjhoorsingh et al., Protection from secondary human immunodeficiency virus type 1 infection inchimpanzees suggests the importance of antigenic boosting and a possible role for cytotoxic T cells, AM NATURAL, 158(2), 2001, pp. 136-143

Authors: Mooij, P Bogers, WMJM Oostermeijer, M Koornstra, W Ten Haaft, PJF Verstrepen, BE Van der Auwera, G Heeney, JL
Citation: P. Mooij et al., Evidence for viral virulence as a predominant factor limiting human immunodeficiency virus vaccine efficacy, J VIROLOGY, 74(9), 2000, pp. 4017-4027

Authors: Balla-Jhagjhoorsingh, S Mooij, P Koopman, G Haaksma, T Teeuwsen, V Heeney, J Bontrop, R
Citation: S. Balla-jhagjhoorsingh et al., Differential cytotoxic T-lymphocyte (CTL) responses in HIV-1 immunised sibling chimpanzees with shared MHC haplotypes, IMMUNOL LET, 66(1-3), 1999, pp. 61-67

Authors: Heeney, J Akerblom, L Barnett, S Bogers, W Davis, D Fuller, D Koopman, G Lehner, T Mooij, P Morein, B Morghen, CD Rosenwirth, B Verschoor, E Wagner, R Wolf, H
Citation: J. Heeney et al., HIV-1 vaccine-induced immune responses which correlate with protection from SHIV infection: compiled preclinical efficacy data from trials with ten different HIV-1 vaccine candidates, IMMUNOL LET, 66(1-3), 1999, pp. 189-195

Authors: Verschoor, EJ Davis, D van Gils, M Koopman, G Mooij, P Oostermeijer, H Ten Haaft, P Verstrepen, B Rosenwirth, B Morein, B Barnett, SW Heeney, JL
Citation: Ej. Verschoor et al., Efforts to broaden HIV-1-specific immunity by boosting with heterologous peptides or envelope protein and the influence of prior exposure to virus, J MED PRIM, 28(4-5), 1999, pp. 224-232

Authors: Verschoor, EJ Mooij, P Oostermeijer, H van der Kolk, M ten Haaft, P Verstrepen, B Sun, YD Morein, B Akerblom, L Fuller, DH Barnett, SW Heeney, JL
Citation: Ej. Verschoor et al., Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in rhesus macaques: Evidence for viral clearance, J VIROLOGY, 73(4), 1999, pp. 3292-3300

Authors: Balla-Jhagjhoorsingh, SS Koopman, G Mooij, P Haaksma, TGM Teeuwsen, VJP Bontrop, RE Heeney, JL
Citation: Ss. Balla-jhagjhoorsingh et al., Conserved CTL epitopes shared between HIV-infected human long-term survivors and chimpanzees, J IMMUNOL, 162(4), 1999, pp. 2308-2314
Risultati: 1-9 |